The natural history of nonalcoholic fatty liver disease: A population-based cohort study

被引:2177
作者
Adams, LA
Lymp, JF
St Sauver, J
Sanderson, SO
Lindor, KD
Feldstein, A
Angulo, P [1 ]
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Div Biostat, Rochester, MN USA
[3] Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN USA
[4] Mayo Clin, Coll Med, Div Anat Pathol, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
D O I
10.1053/j.gastro.2005.04.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The natural history of nonalcoholic fatty liver disease (NAFLD) in the community remains unknown. We sought to determine survival and liver-related morbidity among community-based NAFLD patients. Methods: Four hundred twenty patients diagnosed with NAFLD in Olmsted County, Minnesota, between 1980 and 2000 were identified using the resources of the Rochester Epidemiology Project. Medical records were reviewed to confirm diagnosis and determine outcomes up to 2003. Overall survival was compared with the general Minnesota population of the same age and sex. Results: Mean (SD) age at diagnosis was 49 (15) years; 231 (49%) were male. Mean follow-up was 7.6 (4.0) years (range, 0.1-23.5) culminating in 3.192 person-years follow-up. Overall, 53 of 420 (12.6%) patients died. Survival was lower than the expected survival for the general population (standardized mortality ratio, 1.34; 95% CI, 1.003-1.76; P = .03). Higher mortality was associated with age (hazard ratio per decade, 2.2; 95% CI, 1.7-2.7), impaired fasting glucose (hazard ratio, 2.6; 95% CI, 1.3-5.2), and cirrhosis (hazard ratio, 3.1, 95% CI, 1.2-7.8). Liver disease was the third leading cause of death (as compared with the thirteenth leading cause of death in the general Minnesota population), occurring in 7 (1.7%) subjects. Twenty-one (5%) patients were diagnosed with cirrhosis, and 13 (3.1%) developed liver-related complications, including 1 requiring transplantation and 2 developing hepatocellular carcinoma. Conclusions: Mortality among community-diagnosed NAFLD patients is higher than the general population and is associated with older age, impaired fasting glucose, and cirrhosis. Liver-related death is a leading cause of mortality, although the absolute risk is low.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 35 条
  • [1] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [2] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [3] Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
    Brunt, EM
    Janney, CG
    Di Bisceglie, AM
    Neuschwander-Tetri, BA
    Bacon, BR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) : 2467 - 2474
  • [4] Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
    Bugianesi, E
    Leone, N
    Vanni, E
    Marchesini, G
    Brunello, F
    Carucci, P
    Musso, A
    De Paolis, P
    Capussotti, L
    Salizzoni, M
    Rizzetto, M
    [J]. GASTROENTEROLOGY, 2002, 123 (01) : 134 - 140
  • [5] Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
    Caldwell, SH
    Oelsner, DH
    Iezzoni, JC
    Hespenheide, EE
    Battle, EH
    Driscoll, CJ
    [J]. HEPATOLOGY, 1999, 29 (03) : 664 - 669
  • [6] The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease
    Caldwell, SH
    Crespo, DM
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (04) : 578 - 584
  • [7] Body-mass index and mortality in a prospective cohort of US adults
    Calle, EE
    Thun, MJ
    Petrelli, JM
    Rodriguez, C
    Heath, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) : 1097 - 1105
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] Long term prognosis of fatty liver: risk of chronic liver disease and death
    Dam-Larsen, S
    Franzmann, M
    Andersen, IB
    Christoffersen, P
    Jensen, LB
    Sorensen, TIA
    Becker, U
    Bendtsen, F
    [J]. GUT, 2004, 53 (05) : 750 - 755
  • [10] EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101